learn PP405
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
Search
forLearn
1 / 1 resultsResearch
5 / 191 results
research Quality of Life and Psychosocial Impact of Scarring and Non-Scarring Alopecia in Women
Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.
research The Association of Depression, Loneliness, and Internet Addiction Levels in Male Bachelor of Medicine, Bachelor of Surgery Students With Androgenetic Alopecia Male Pattern Baldness in a Medical College in Kolar, India
Male pattern baldness in medical students is linked to higher depression, loneliness, and internet addiction.
research Acne Development in Male Androgenetic Alopecia
Acne is more common in men with male pattern baldness due to increased hormone levels.
research Congenital Adrenal Hyperplasia: Comprehensive Overview and Clinical Management
The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.
research The Role of Androgens in Hormone Replacement Therapy
Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.
Community Join
5 / 11 resultscommunity UCLA scientists found a molecule — PP405 — that wakes up sleeping hair follicles and tells them, “Do your job.”
PP405 is a promising molecule that may reactivate dormant hair follicles, potentially offering a new treatment for hair loss. It is in phase 2 trials, with possible availability between 2027 and 2030.
community Did Scientists Just Cure Baldness? UCLA’s New Molecule Could Revolutionize Hair Growth
PP405 shows promise for hair growth but may need continuous use like Minoxidil. Current treatments include Minoxidil, finasteride, and dutasteride, with skepticism about a true cure due to financial interests.
community 2 years of me being on fin+min
The conversation discusses hair loss treatments, specifically the use of oral finasteride and topical minoxidil, with the user sharing their two-year progress and routine. The user experienced initial shedding but saw improvements after six months, and they recently started taking dutasteride.
community The PP405 news are the best news we've had in the last 20 or more years.
PP405 significantly improves hair density, outperforming finasteride, with 31% of users seeing over 20% improvement in four weeks. Concerns exist about its availability, cost, and long-term effects.
community Molecule PP405: A Research Team Backed By Google Ventures Has Discovered One Of The Most Promising Solutions For Hair Loss To Date
PP405 is a promising new treatment for hair loss that activates dormant stem cells in hair follicles, potentially bypassing the effects of DHT. It is currently in phase 2 trials and could be available between 2027 and 2030, but it is not considered a definitive cure.